Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 22: SYMPLICITY HTN-3: RDN in Pts With Uncontrolled Hypertension
Author(s): Deepak L Bhatt Added: 1 year ago
TCT 22 - Dr Deepak Bhatt (Brigham and Women's Hospital, US) joins us to discuss the findings of SYMPLICITY HTN-3 (NCT01418261), originally presented at TCT Conference 2022. SYMPLICITY is a randomized, sham-controlled clinical trial studying the efficacy and safety of Symplicity Flex renal denervation catheter (Medtronic)for uncontrolled hypertension. Questions: 1. What was the rationale for this… View more

Prevention & Chronic Conditions

Intervention
Heart Failure and Aortic Stenosis - What TAVI Can Offer
Author(s): Victoria Delgado , Jose Luis Zamorano , Davide Capodanno , et al Added: 1 year ago
In this video series, first presented at the ESC Congress 2022, held in Barcelona, Prof Ralph Stephan von Bardeleben, Prof Jose LuisZamorano, Dr Victoria Delgado, Prof DavideCapodanno and Dr SashaKoul discuss the diagnosis of low flow/low gradient aortic stenosis, which patients gain the most benefit from TAVI and how to avoid heart failure in aortic stenosis patients. Join this international… View more

Imaging & Diagnostics

Heart Failure
Individualising Antithrombotic Strategies for Established CAD
Author(s): Marco Valgimigli , Vijay Kunadian , Pascal Vranckx , et al Start date: Feb 22, 2023

Prevention & Chronic Conditions

Intervention
PCI Versus CABG In Patients With Type 1 Diabetes And Multivessel Disease
Author(s): Martin Holzmann Added: 6 years ago
Martin Holzmann discusses PCI versus CABG in patients with Type 1 diabetes and multivessel disease. Filmed by Radcliffe Cardiology on-site at ESC 2017. View more

Vascular Disease and Surgery

Prevention & Chronic Conditions
RADIANCE-HTN: 6Mo Outcomes of RDN Vs a Sham Procedure for Resistant Hypert
Author(s): Ajay J Kirtane Added: 2 years ago
In this short summary interview, Dr. Ajay Kirtane (Columbia University Medical Center, US) shares the six-month outcomes of a randomized trial of renal denervation (RDN) versus a sham procedure for resistant hypertension. The RADIANCE-TRIO Trial, presented first at TCT 2021, showed that the additional effects of pharmacologic intervention with maintenance of a BP-lowering effect of endovascular… View more

Intervention
Decompensated Heart Failure: Taking the Acute Out of Decompensation
Author(s): Biykem Bozkurt Added: 2 months ago

Intervention
Plenary Lecture: The Evolution of Cardiovascular Disease Worldwide: New Frontiers
Author(s): Valentin Fuster Added: 6 years ago

Heart Failure
How to Unload the Heart on Extracorporeal Membrane Oxygenation
Author(s): Bart Meyns Added: 4 years ago

MI/ACS
British Heart Rhythm Society (formerly known as Heart Rhythm UK) is dedicated to improving all aspects of arrhythmia care and electrical device based therapies along with acting as a unifying focus for those professionals involved. The society was formed in 2005 by the amalgamation of the British Pacing and Electrophysiology Group (BPEG), the British Association of Arrhythmia Nurses (BANA) and… View more
Individualising Antithrombotic Strategies for Established CAD
Author(s): Marco Valgimigli , Eliano Navarese , Pascal Vranckx Added: 1 year ago
This three-part programme delves into the critical importance of individualised antithrombotic treatment in both Acute Coronary Syndrome (ACS) and Chronic Coronary Syndrome (CCS). Part one of this programme presents two compelling patient case studies.Prof Pascal Vranckx (Hartcentrum Hasselt, BE) presents a complex 62-year old male with stable angina and HFrEF, undergoing an elective… View more

Anticoagulation

MI/ACS